Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients von Karachaliou, Niki, Gonzalez-Cao, Maria, Crespo, Guillermo, Drozdowskyj, Ana, Aldeguer, Erika, Gimenez-Capitan, Ana, Teixido, Cristina, Molina-Vila, Miguel Angel, Viteri, Santiago, De Los Llanos Gil, Maria, Algarra, Salvador Martin, Perez-Ruiz, Elisabeth, Marquez-Rodas, Ivan, Rodriguez-Abreu, Delvys, Blanco, Remedios, Puertolas, Teresa, Royo, Maria Angeles, Rosell, Rafael

Volltext

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer von Jacobsen, Kirstine, Bertran-Alamillo, Jordi, Molina, Miguel Angel, Teixidó, Cristina, Karachaliou, Niki, Pedersen, Martin Haar, Castellví, Josep, Garzón, Mónica, Codony-Servat, Carles, Codony-Servat, Jordi, Giménez-Capitán, Ana, Drozdowskyj, Ana, Viteri, Santiago, Larsen, Martin R., Lassen, Ulrik, Felip, Enriqueta, Bivona, Trever G., Ditzel, Henrik J., Rosell, Rafael

Volltext

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC von Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Codony Servat, Jordi, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, de Marinis, Filipo, Passaro, Antonio, Carcereny, Enric, Reguart, Noemi, Campelo, Charo Garcia, Teixido, Christina, Sperduti, Isabella, Rodriguez, Sonia, Lazzari, Chiara, Verlicchi, Alberto, de Aguirre, Itziar, Queralt, Cristina, Wei, Jia, Estrada, Roger, Puig de la Bellacasa, Raimon, Ramirez, Jose Luis, Jacobson, Kirstine, Ditzel, Henrik J, Santarpia, Mariacarmela, Viteri, Santiago, Molina, Migual Angel, Zhou, Caicun, Cao, Peng, Ma, Patrick C, Bivona, Trever G, Rosell, Rafael

Volltext

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial von Gonzalez-Cao, Maria, Mayo de las Casas, Clara, Oramas, Juana, Berciano-Guerrero, Miguel A., de la Cruz, Luis, Cerezuela, Pablo, Arance, Ana, Muñoz-Couselo, Eva, Espinosa, Enrique, Puertolas, Teresa, Diaz Beveridge, Roberto, Ochenduszko, Sebastian, Villanueva, Maria-Jose, Basterretxea, Laura, Bellido, Lorena, Rodriguez, Delvys, Campos, Begoña, Montagut, Clara, Drozdowskyj, Ana, Molina, Miguel A., Lopez-Martin, Jose Antonio, Berrocal, Alfonso

Volltext

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis von Karachaliou, Niki, Chaib, Imane, Cardona, Andres Felipe, Berenguer, Jordi, Bracht, Jillian Wilhelmina Paulina, Yang, Jie, Cai, Xueting, Wang, Zhigang, Hu, Chunping, Drozdowskyj, Ana, Servat, Carles Codony, Servat, Jordi Codony, Ito, Masaoki, Attili, Ilaria, Aldeguer, Erika, Capitan, Ana Gimenez, Rodriguez, July, Rojas, Leonardo, Viteri, Santiago, Molina-Vila, Miguel Angel, Ou, Sai-Hong Ignatius, Okada, Morihito, Mok, Tony S, Bivona, Trever G, Ono, Mayumi, Cui, Jean, Ramón Y Cajal, Santiago, Frias, Alex, Cao, Peng, Rosell, Rafael

Volltext

Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer von Pedraz-Valdunciel, Carlos, Giannoukakos, Stavros, Giménez-Capitán, Ana, Fortunato, Diogo, Filipska, Martyna, Bertran-Alamillo, Jordi, Bracht, Jillian W P, Drozdowskyj, Ana, Valarezo, Joselyn, Zarovni, Natasa, Fernández-Hilario, Alberto, Hackenberg, Michael, Aguilar-Hernández, Andrés, Molina-Vila, Miguel Ángel, Rosell, Rafael

Volltext

BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib von Karachaliou, Niki, Arrieta, Oscar, Giménez-Capitán, Ana, Aldeguer, Erika, Drozdowskyj, Ana, Chaib, Imane, Reguart, Noemí, Garcia-Campelo, Rosario, Chen, Jing-Hua, Molina-Vila, Miguel Angel, Rosell, Rafael

Volltext

The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC T... von COSTA, Carlota, MOLINA, Miguel Angel, MAJEM, Margarita, FELIP, Enriqueta, CARCERENY, Enric, GARCIA-CAMPELO, Rosario, VITERI, Santiago, TARON, Miquel, MAYUMI ONO, GIANNIKOPOULOS, Petros, BIVONA, Trever, ROSELL, Rafael, DROZDOWSKYJ, Ana, GIMENEZ-CAPITAN, Ana, BERTRAN-ALAMILLO, Jordi, KARACHALIOU, Niki, GERVAIS, Radj, MASSUTI, Bartomeu, JIA WEI, MORAN, Teresa

Volltext

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-l... von Rosell, Rafael, Dr, Carcereny, Enric, MD, Gervais, Radj, MD, Vergnenegre, Alain, Prof, Massuti, Bartomeu, MD, Felip, Enriqueta, MD, Palmero, Ramon, MD, Garcia-Gomez, Ramon, MD, Pallares, Cinta, MD, Sanchez, Jose Miguel, MD, Porta, Rut, MD, Cobo, Manuel, MD, Garrido, Pilar, MD, Longo, Flavia, MD, Moran, Teresa, MD, Insa, Amelia, MD, De Marinis, Filippo, MD, Corre, Romain, MD, Bover, Isabel, MD, Illiano, Alfonso, MD, Dansin, Eric, MD, de Castro, Javier, MD, Milella, Michele, MD, Reguart, Noemi, MD, Altavilla, Giuseppe, MD, Jimenez, Ulpiano, MD, Provencio, Mariano, MD, Moreno, Miguel Angel, MD, Terrasa, Josefa, MD, Muñoz-Langa, Jose, MD, Valdivia, Javier, MD, Isla, Dolores, MD, Domine, Manuel, MD, Molinier, Olivier, MD, Mazieres, Julien, Prof, Baize, Nathalie, MD, Garcia-Campelo, Rosario, MD, Robinet, Gilles, MD, Rodriguez-Abreu, Delvys, MD, Lopez-Vivanco, Guillermo, MD, Gebbia, Vittorio, MD, Ferrera-Delgado, Lioba, MD, Bombaron, Pierre, MD, Bernabe, Reyes, MD, Bearz, Alessandra, MD, Artal, Angel, MD, Cortesi, Enrico, MD, Rolfo, Christian, MD, Sanchez-Ronco, Maria, PhD, Drozdowskyj, Ana, PhD, Queralt, Cristina, PhD, de Aguirre, Itziar, PhD, Ramirez, Jose Luis, PhD, Sanchez, Jose Javier, Prof, Molina, Miguel Angel, PhD, Taron, Miquel, PhD, Paz-Ares, Luis, MD

Volltext

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer von Nilsson, R Jonas A, Karachaliou, Niki, Berenguer, Jordi, Gimenez-Capitan, Ana, Schellen, Pepijn, Teixido, Cristina, Tannous, Jihane, Kuiper, Justine L, Drees, Esther, Grabowska, Magda, van Keulen, Marte, Heideman, Danielle A M, Thunnissen, Erik, Dingemans, Anne-Marie C, Viteri, Santiago, Tannous, Bakhos A, Drozdowskyj, Ana, Rosell, Rafael, Smit, Egbert F, Wurdinger, Thomas

Volltext

Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL) von Garcia-Campelo, Rosario, Arrieta, Oscar, Massuti, Bartomeu, Rodriguez-Abreu, Delvys, Granados, Ana Laura Ortega, Majem, Margarita, Vicente, David, Lianes, Pilar, Bosch-Barrera, Joaquim, Insa, Amelia, Dómine, Manuel, Reguart, Noemí, Guirado, María, Sala, María Ángeles, Vázquez-Estevez, Sergio, Caro, Reyes Bernabé, Drozdowskyj, Ana, Verdú, Ana, Karachaliou, Niki, Molina-Vila, Miguel Angel, Rosell, Rafael

Volltext

Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors von Salvia, Roser, Rico, Laura G, Morán, Teresa, Bradford, Jolene A, Ward, Michael D, Drozdowskyj, Ana, Climent-Martí, Joan, Martínez-Cáceres, Eva M, Rosell, Rafael, Petriz, Jordi

Volltext

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale von Bracht, Jillian Wilhelmina Paulina, Karachaliou, Niki, Bivona, Trever, Lanman, Richard B., Faull, Iris, Nagy, Rebecca J., Drozdowskyj, Ana, Berenguer, Jordi, Fernandez-Bruno, Manuel, Molina-Vila, Miguel Angel, Rosell, Rafael

Volltext

Cancer Stem Cell Biomarkers in EGFR-Mutation–Positive Non–Small-Cell Lung Cancer von Codony-Servat, Jordi, Codony-Servat, Carles, Cardona, Andrés Felipe, Giménez-Capitán, Ana, Drozdowskyj, Ana, Berenguer, Jordi, Bracht, Jillian Wilhelmina Paulina, Ito, Masaoki, Karachaliou, Niki, Rosell, Rafael

Volltext

Results of phase II randomized study of intermittent versus continuous schedule of vemurafenib plus cobimetinib in BRAF-mutated advanced melanoma von Gonzalez-Cao, Maria, Mayo de las Casas, Clara, Oramas, Juana, Berciano-Guerrero, Miguel-Angel, De la Cruz, Luis, Cerezuela-Fuentes, Pablo, Arance, Ana Maria, Muñoz-Couselo, Eva, Espinosa, Enrique, Puértolas, Teresa, Diaz Beveridge, Robert, Ochenduszko, Sebastian, Villanueva Silva, Maria Jose, Basterretxea, Laura, Bellido, Lorena, Rodriguez-Abreu, Delvys, Drozdowskyj, Ana, Molina Vila, Miguel Angel, Lopez-Martin, Jose Antonio, Berrocal, Alfonso

Volltext

Access to melanoma drugs in Spain: a cross-sectional survey von Gonzalez-Cao, Maria, Puertolas, Teresa, Manzano, Jose Luis, Maldonado, Cayetana, Yelamos, Oriol, Berciano-Guerrero, Miguel Ángel, Cerezuela, Pablo, Martin-Liberal, Juan, Muñoz-Couselo, Eva, Espinosa, Enrique, Drozdowskyj, Ana, Berrocal, Alfonso, Soria, Ainara, Marquez-Rodas, Ivan, Martin-Algarra, Salvador, Quindos, Maria, Puig, Susana

Volltext

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors von Gonzalez-Cao, Maria, Mayo-de-Las-Casas, Clara, Molina-Vila, Miguel A, De Mattos-Arruda, Leticia, Muñoz-Couselo, Eva, Manzano, Jose L, Cortes, Javier, Berros, Jose P, Drozdowskyj, Ana, Sanmamed, Miguel, Gonzalez, Alvaro, Alvarez, Carlos, Viteri, Santiago, Karachaliou, Niki, Martin Algarra, Salvador, Bertran-Alamillo, Jordi, Jordana-Ariza, Nuria, Rosell, Rafael

Volltext

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC) von Karachaliou, Niki, Cardona, Andres Felipe, Bracht, Jillian Wilhelmina Paulina, Aldeguer, Erika, Drozdowskyj, Ana, Fernandez-Bruno, Manuel, Chaib, Imane, Berenguer, Jordi, Santarpia, Mariacarmela, Ito, Masaoki, Codony-Servat, Jordi, Rosell, Rafael

Volltext

Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis von Cerezuela-Fuentes, Pablo, Gonzalez-Cao, Maria, Puertolas, Teresa, Manzano, Jose Luis, Maldonado, Cayetana, Yelamos, Oriol, Berciano-Guerrero, Miguel A, Martin-Liberal, Juan, Muñoz-Couselo, Eva, Espinosa, Enrique, Drozdowskyj, Ana, Berrocal, Alfonso, Soria, Ainara, Marquez-Rodas, Ivan, Martin-Algarra, Salvador, Quindos, Maria, Puig, Susana

Volltext

Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer von Karachaliou, Niki, Bracht, Jillian Wilhelmina Paulina, Fernandez Bruno, Manuel, Drozdowskyj, Ana, Gimenez Capitan, Ana, Moran, Teresa, Carcereny, Enric, Cobo, Manuel, Domine, Manuel, Chaib, Imane, Ramirez, Jose Luis, Camps, Carlos, Provencio, Mariano, Vergnenegre, Alain, Lopez-Vivanco, Guillermo, Majem, Margarita, Massuti, Bartomeu, Rosell, Rafael

Volltext